SRAM
ATRS

Spouting Rock Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Spouting Rock Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,289
Closed -$201K – 72
2021
Q4 		$201K Buy
+56,289
New +$197K 0.16% 59
2021
Q3 		– Sell
-51,213
Closed -$223K – 220
2021
Q2 		$223K Buy
+51,213
New +$209K 0.07% 196

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Spouting Rock Asset Management's ATRS Position: Q1 2022 in Review

Spouting Rock Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2022, closing a stake of 56,289 shares — an estimated $201K sold.

Spouting Rock Asset Management first reported a position in ATRS in Q2 2021 and held it in 2 quarters. The position peaked at $223K in Q2 2021. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • Spouting Rock Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2022 after selling out during the quarter.
  • Spouting Rock Asset Management sold 56,289 Antares Pharma, Inc. shares in Q1 2022, an estimated $201K.
  • Spouting Rock Asset Management first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 2 quarters.
  • Spouting Rock Asset Management's Antares Pharma, Inc. position peaked at $223K in Q2 2021.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Spouting Rock Asset Management's 13F filing for Q1 2022, filed 13 May 2022.